Interim Phase 4 Data Support TAKHZYRO as an Effective Treatment to Reduce Attacks in Hereditary Angioedema Patients
− Interim Real-World Data from Phase 4 EMPOWER Study Show Attack Rate Reduction and Improvement in Treatment Satisfaction and Other Patient-Reported Outcome Scores1 − Interim Patient-Reported Outcomes...